Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP313850.RAgZK-hOL6-hNqRZsWZr2GfNLvnXd72zX4n5VTiB0ye0A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP313850.RAgZK-hOL6-hNqRZsWZr2GfNLvnXd72zX4n5VTiB0ye0A130_assertion type Assertion NP313850.RAgZK-hOL6-hNqRZsWZr2GfNLvnXd72zX4n5VTiB0ye0A130_head.
- NP313850.RAgZK-hOL6-hNqRZsWZr2GfNLvnXd72zX4n5VTiB0ye0A130_assertion description "[Five cases (10%) were cyclin D1-positive in primary lesion and cyclin D1-negative in lymph node, and 12 cases (24%) were cyclin D1-negative in primary lesion and cyclin D1-positive in lymph nodes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP313850.RAgZK-hOL6-hNqRZsWZr2GfNLvnXd72zX4n5VTiB0ye0A130_provenance.
- NP313850.RAgZK-hOL6-hNqRZsWZr2GfNLvnXd72zX4n5VTiB0ye0A130_assertion evidence source_evidence_literature NP313850.RAgZK-hOL6-hNqRZsWZr2GfNLvnXd72zX4n5VTiB0ye0A130_provenance.
- NP313850.RAgZK-hOL6-hNqRZsWZr2GfNLvnXd72zX4n5VTiB0ye0A130_assertion SIO_000772 11295092 NP313850.RAgZK-hOL6-hNqRZsWZr2GfNLvnXd72zX4n5VTiB0ye0A130_provenance.
- NP313850.RAgZK-hOL6-hNqRZsWZr2GfNLvnXd72zX4n5VTiB0ye0A130_assertion wasDerivedFrom befree-2016 NP313850.RAgZK-hOL6-hNqRZsWZr2GfNLvnXd72zX4n5VTiB0ye0A130_provenance.
- NP313850.RAgZK-hOL6-hNqRZsWZr2GfNLvnXd72zX4n5VTiB0ye0A130_assertion wasGeneratedBy ECO_0000203 NP313850.RAgZK-hOL6-hNqRZsWZr2GfNLvnXd72zX4n5VTiB0ye0A130_provenance.